STEPHANIE DORSEY: Open Payments
NPI 1780320689 · ROYERSFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$897 in 48 payments from 19 companies in 2025. Trend: 2023 $988 · 2024 $555 · 2025 $897
Food & beverage: $897
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $206 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $157 |
| Lilly USA, LLC | 4 | $66 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| PFIZER INC. | 2 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| Astellas Pharma US Inc | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
Products named: XIFAXAN, Ozempic, LEQVIO, ELIQUIS, MOUNJARO, JARDIANCE, AIRSUPRA, Rybelsus.
Industry payments across PA — which companies pay providers there.
